Phase 2 Ischemic Clinical Trials
74 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 74 trials
Recruiting
Phase 1Phase 2
A Study of ASP2246 for People Who Have Movement Problems Caused by Brain Injury After a Stroke
Chronic Ischemic Stroke
Astellas Pharma Inc84 enrolled2 locationsNCT07318714
Recruiting
Phase 2
Exploratory Study of ADR-002K for Heart Failure Patients With Ischemic Heart Disease Who Undergo CABG
Ischemic Heart Disease
Rohto Pharmaceutical Co., Ltd.50 enrolled1 locationNCT07192211
Recruiting
Phase 2
Fructose for Acute Ischemic Stroke
Acute Ischemic Stroke
Ji Xunming,MD,PhD46 enrolled1 locationNCT07626541
Recruiting
Phase 1Phase 2
Human Placenta-derived 3D Mesenchymal Stem Cells(Guojianqingke)
Acute Ischemic Stroke
Chinese PLA General Hospital24 enrolled1 locationNCT07635758
Recruiting
Phase 2
Strategy for Improving Stroke Treatment Response
Ischemic Stroke
Translational Sciences, Inc.300 enrolled52 locationsNCT05948566
Recruiting
Phase 2Phase 3
Minocycline After Successful Endovascular Thrombectomy Recanalization in Acute Anterior Circulation Large Vessel Occlusion (ATTRACTION-MINOA)
Acute Ischemic StrokeMinocyclineAnterior Circulation Brain Infarction+2 more
Xiang Luo860 enrolled1 locationNCT07594314
Recruiting
Phase 2Phase 3
Minocycline After Successful Endovascular Thrombectomy Recanalization in Posterior Circulation Arterial Occlusion (ATTRACTION-MINOP)
Acute Ischemic StrokeMinocyclineArterial Occlusion+2 more
Xiang Luo234 enrolled1 locationNCT07594301
Recruiting
Phase 2Phase 3
Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke
Central Nervous System DiseasesCerebrovascular DisordersIschemic Stroke, Acute+1 more
University of Melbourne462 enrolled12 locationsNCT05892510
Recruiting
Phase 2
Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
Acute Ischemic Stroke
Basking Biosciences, Inc.228 enrolled25 locationsNCT06226805
Recruiting
Phase 2
Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrOmal Cells in Ischemic Cardiomyopathy
Ischemic Heart Disease
Roberto Bolli60 enrolled3 locationsNCT06145035
Recruiting
Phase 2
Efficacy and Safety of QD202 in Participants With Acute Ischemic Stroke Undergoing Thrombolysis Excluding Endovascular Thrombectomy
Acute Ischemic Stroke
Shanghai QuietD Biotechnology Co., Ltd.120 enrolled14 locationsNCT07581210
Recruiting
Phase 2
Modulation of Cerebral Ischemia by Albumin
Ischemic Stroke
University Hospital Hradec Kralove100 enrolled1 locationNCT07415655
Recruiting
Phase 2
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
Acute Ischemic Stroke
Shanghai Pharmaceuticals Holding Co., Ltd300 enrolled28 locationsNCT05686642
Recruiting
Phase 2
Head Down Tilt 15° to Increase Collateral Flow in Acute Ischemic Stroke
Acute Ischemic Stroke
University of Milano Bicocca118 enrolled6 locationsNCT06297863
Recruiting
Phase 2
Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke
Acute Ischemic Stroke
University of California, Los Angeles120 enrolled3 locationsNCT06440707
Recruiting
Phase 2Phase 3
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
StrokeAcute StrokeIschemic Stroke
DiaMedica Therapeutics Inc728 enrolled66 locationsNCT05065216
Recruiting
Phase 2
A Study of TAK-755 in Adults With Acute Ischemic Stroke
Acute Ischemic Stroke
Takeda222 enrolled1 locationNCT07392450
Recruiting
Phase 2
Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
Sickle Cell DiseaseOsteonecrosisAvascular Necrosis+2 more
University of California, Davis30 enrolled1 locationNCT06016634
Recruiting
Phase 2
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia
Hypoxic-ischemic encephalopathy.
ReAlta Life Sciences, Inc.70 enrolled15 locationsNCT05778188
Recruiting
Phase 2
Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Tenecteplase (RITIS-TNK2)
Ischemic Stroke
General Hospital of Shenyang Military Region198 enrolled1 locationNCT07375966